By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
about
Effect of plant sterols on the lipid profile of patients with hypercholesterolaemia. Randomised, experimental studyThe preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factorsProbiotic fermented milk or isolated probiotic bacteria for primary prevention of cardiovascular disease in adultsReduction in saturated fat intake for cardiovascular diseaseEzetimibe for primary hypercholesterolemiaReduced or modified dietary fat for preventing cardiovascular diseaseHMG CoA reductase inhibitors (statins) for dialysis patientsProbiotic fermented milk or isolated probiotic bacteria for primary prevention of cardiovascular disease in adultsLipid-lowering agents for nephrotic syndromeAcupuncture for primary hypercholesterolaemiaReduced or modified dietary fat for preventing cardiovascular diseaseHMG CoA reductase inhibitors (statins) for dialysis patientsHMG CoA reductase inhibitors (statins) for dialysis patientsDietary advice for reducing cardiovascular riskEzetimibe for primary hypercholesterolemiaPharmacotherapy for weight loss in adults with type 2 diabetes mellitusDietary advice for reducing cardiovascular riskLipid-lowering agents for nephrotic syndromeThe evidence base for fat guidelines: a balanced dietRisk factor thresholds: their existence under scrutinySystematic review of dietary intervention trials to lower blood total cholesterol in free-living subjectsCould targeted food taxes improve health?Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysisA strategy to reduce cardiovascular disease by more than 80%A review of clinical trials in dietary interventions to decrease the incidence of coronary artery diseaseThe effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]Beyond the Evidence of the New Hypertension Guidelines. Blood pressure measurement - is it good enough for accurate diagnosis of hypertension? Time might be in, for a paradigm shift (I)Comparative quantification of health risks conceptual framework and methodological issues.Distribution of major health risks: findings from the Global Burden of Disease studyPlant sterols: factors affecting their efficacy and safety as functional food ingredientsOptimal Use of Plant Stanol Ester in the Management of HypercholesterolemiaBenefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetesContributions of risk factors and medical care to cardiovascular mortality trendsWill changes in primary care improve health outcomes? Modelling the impact of financial incentives introduced to improve quality of care in the UKComparing primary prevention with secondary prevention to explain decreasing coronary heart disease death rates in Ireland, 1985-2000Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a reviewPantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigationPlant stanol esters are potentially cost-effective in the prevention of coronary heart disease in men: Bayesian modelling approachInduction of phase 2 antioxidant enzymes by broccoli sulforaphane: perspectives in maintaining the antioxidant activity of vitamins a, C, and eLDL-Cholesterol: Standards of Treatment 2016: A German Perspective.
P2860
Q21254688-6B6FC951-B392-44D1-BF1F-06AC1968E34FQ21563399-C004DC70-42A8-44BF-A6D0-C02A7D005FC6Q24185844-83ACD575-AE9D-4188-B453-B8956D6B96CDQ24187203-EACB0E27-6DB4-47AB-8A17-D3D3FBF3D595Q24187681-4D87A35B-963D-4D49-9A67-9A145C1B2CFCQ24197817-2789E699-3881-41E9-B9B9-6FA1A1A898CCQ24198108-76BFA04C-6829-4454-AD22-C512452954A6Q24200391-F83B1414-0CC6-4C9D-A872-A5C2C0931EA4Q24201863-63A38B72-279E-4350-BBB5-C0EC670B0E81Q24202765-1A45DF91-42BC-4B77-B20E-F39C0E4343ACQ24235559-5DEFCF62-B942-4F63-8C51-A80812F5BD76Q24239881-D0313C29-C76E-4703-AFCD-CFBC912E1EA6Q24241531-229C197C-F9D4-409E-8F9D-D0AA7C8E3AF0Q24243266-98565B28-9B16-4BE2-9D56-208F54282739Q24244704-6E083435-0169-403E-8318-A84323A036B0Q24245173-11C5663B-FE68-437F-AC2D-77C7AF6AC90EQ24245882-611BC59F-76B2-416C-BEAA-822D8AD2652DQ24246691-AF660E2C-9474-42FB-B7B1-505499B5EAF3Q24289029-67791BED-0074-481C-A514-ABE9B536BB97Q24527206-CEE65923-522D-4370-B73E-BEBB142BF16BQ24598858-EB2DDB32-A9AB-4832-BF0A-5C4A7C33FA73Q24643428-075A0937-3EDE-438A-9AF8-3EE28A88F7ECQ24679573-02A63493-20A2-4C12-A481-0AA9F7466FD8Q24679592-840684B4-0868-41C9-A258-CEF5428AFB2DQ24793178-62BC8F52-EE93-4A68-9830-55072A9B1117Q24793837-3955F2E7-D347-40F6-8717-6C97829184EAQ24795084-FE56FFA1-510C-4BD0-A2B7-E63C92B694FDQ24801397-6A7A5592-1AD8-4AC0-BDE4-70895DBE7BB8Q24802507-67B36991-2A9A-44E0-9DB6-ABB85AF2E7DDQ24803635-4418A555-208F-411F-842D-4B914DD9A92FQ26778700-D6C3C824-1A39-4CF8-8C62-12AADEDB69EEQ26853571-91788D74-5A6A-42D7-8B3B-0A8458F4FBB0Q27012592-DA41B560-0994-4556-AB30-F13C74B7A4DCQ28168828-47D8FC75-77AA-4CEF-9846-1475ABE47F2BQ28217496-C9AF532A-D985-4638-9256-81CF9A743E3DQ28220294-9C1B03DC-538B-4E5C-A608-E04F6CEBB7A9Q28235346-DA32F2E5-0B6E-4BAA-B9DC-14C9F6419242Q28298648-BF9A7CC6-D0BC-47E2-92BA-E0CED74BA82AQ28395954-F3F9F797-9B9B-47FF-996B-032544BBCC25Q30248925-7CA228A2-7B11-4118-A692-0FEB82A53817
P2860
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
By how much and how quickly do ...... sk of ischaemic heart disease?
@en
type
label
By how much and how quickly do ...... sk of ischaemic heart disease?
@en
prefLabel
By how much and how quickly do ...... sk of ischaemic heart disease?
@en
P2093
P2860
P356
P1433
P1476
By how much and how quickly do ...... sk of ischaemic heart disease?
@en
P2093
P2860
P304
P356
10.1136/BMJ.308.6925.367
P407
P577
1994-02-01T00:00:00Z